author_facet Benkwitz, Claudia
Garrison, James C.
Linden, Joel
Durieux, Marcel E.
Hollmann, Markus W.
Benkwitz, Claudia
Garrison, James C.
Linden, Joel
Durieux, Marcel E.
Hollmann, Markus W.
author Benkwitz, Claudia
Garrison, James C.
Linden, Joel
Durieux, Marcel E.
Hollmann, Markus W.
spellingShingle Benkwitz, Claudia
Garrison, James C.
Linden, Joel
Durieux, Marcel E.
Hollmann, Markus W.
Anesthesiology
Lidocaine Enhances GαiProtein Function
Anesthesiology and Pain Medicine
author_sort benkwitz, claudia
spelling Benkwitz, Claudia Garrison, James C. Linden, Joel Durieux, Marcel E. Hollmann, Markus W. 0003-3022 Ovid Technologies (Wolters Kluwer Health) Anesthesiology and Pain Medicine http://dx.doi.org/10.1097/00000542-200311000-00015 <jats:sec> <jats:title>Background</jats:title> <jats:p>Local anesthetics inhibit several G protein-coupled receptors by interaction with the Galphaq protein subunit. It is not known whether this effect on G protein function can be extrapolated to other classes of G proteins. The authors investigated interactions of lidocaine with the human adenosine 1 receptor (hA1R)-coupled signaling pathway. Activated A1Rs couple to adenylate cyclase via the pertussis toxin sensitive Galphai protein, thereby decreasing cyclic adenosine monophosphate formation. A1Rs are widely expressed and abundant in the spinal cord, brain, and heart. Interactions of LAs with the hA1R-coupled transduction cascade therefore might produce a broad range of clinically relevant effects.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>The function of hA1Rs stably expressed in Chinese hamster ovary cells was determined with assays of cyclic adenosine monophosphate, receptor binding, and guanosine diphosphate/guanosine triphosphate gamma35S exchange by using reconstituted defined G protein subunits. Involvement of phosphodiesterase and Galphai was characterized by using the phosphodiesterase inhibitor rolipram and pertussis toxin, respectively.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>Lidocaine (10-9-10-1 M) had no significant effects on agonist or antagonist binding to the hA1R or on receptor-G protein interactions. However, cyclic adenosine monophosphate levels were reduced significantly to 50% by the LAs, even in the absence of an A1R agonist or presence of an A1R antagonist. This effect was unaffected by rolipram (10 mum), but abolished completely by pretreatment with pertussis toxin, which inactivates the Galphai protein. Therefore, the main target site for LAs in this pathway is located upstream from adenylate cyclase.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions</jats:title> <jats:p>Lidocaine potentiates Galphai-coupled A1R signaling by reducing cyclic adenosine monophosphate production. The study suggests an interaction site for LAs in a Galphai-coupled signaling pathway, with the Galphai protein representing the prime candidate. Taken together with previous results showing inhibitory LA interactions on the Galphaq protein subunit, the data in the current study support the hypothesis that specific G protein subunits represent alternative sites of LA action.</jats:p> </jats:sec> Lidocaine Enhances GαiProtein Function Anesthesiology
doi_str_mv 10.1097/00000542-200311000-00015
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5Ny8wMDAwMDU0Mi0yMDAzMTEwMDAtMDAwMTU
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5Ny8wMDAwMDU0Mi0yMDAzMTEwMDAtMDAwMTU
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
imprint Ovid Technologies (Wolters Kluwer Health), 2003
imprint_str_mv Ovid Technologies (Wolters Kluwer Health), 2003
issn 0003-3022
issn_str_mv 0003-3022
language English
mega_collection Ovid Technologies (Wolters Kluwer Health) (CrossRef)
match_str benkwitz2003lidocaineenhancesgaiproteinfunction
publishDateSort 2003
publisher Ovid Technologies (Wolters Kluwer Health)
recordtype ai
record_format ai
series Anesthesiology
source_id 49
title Lidocaine Enhances GαiProtein Function
title_unstemmed Lidocaine Enhances GαiProtein Function
title_full Lidocaine Enhances GαiProtein Function
title_fullStr Lidocaine Enhances GαiProtein Function
title_full_unstemmed Lidocaine Enhances GαiProtein Function
title_short Lidocaine Enhances GαiProtein Function
title_sort lidocaine enhances gαiprotein function
topic Anesthesiology and Pain Medicine
url http://dx.doi.org/10.1097/00000542-200311000-00015
publishDate 2003
physical 1093-1101
description <jats:sec> <jats:title>Background</jats:title> <jats:p>Local anesthetics inhibit several G protein-coupled receptors by interaction with the Galphaq protein subunit. It is not known whether this effect on G protein function can be extrapolated to other classes of G proteins. The authors investigated interactions of lidocaine with the human adenosine 1 receptor (hA1R)-coupled signaling pathway. Activated A1Rs couple to adenylate cyclase via the pertussis toxin sensitive Galphai protein, thereby decreasing cyclic adenosine monophosphate formation. A1Rs are widely expressed and abundant in the spinal cord, brain, and heart. Interactions of LAs with the hA1R-coupled transduction cascade therefore might produce a broad range of clinically relevant effects.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>The function of hA1Rs stably expressed in Chinese hamster ovary cells was determined with assays of cyclic adenosine monophosphate, receptor binding, and guanosine diphosphate/guanosine triphosphate gamma35S exchange by using reconstituted defined G protein subunits. Involvement of phosphodiesterase and Galphai was characterized by using the phosphodiesterase inhibitor rolipram and pertussis toxin, respectively.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>Lidocaine (10-9-10-1 M) had no significant effects on agonist or antagonist binding to the hA1R or on receptor-G protein interactions. However, cyclic adenosine monophosphate levels were reduced significantly to 50% by the LAs, even in the absence of an A1R agonist or presence of an A1R antagonist. This effect was unaffected by rolipram (10 mum), but abolished completely by pretreatment with pertussis toxin, which inactivates the Galphai protein. Therefore, the main target site for LAs in this pathway is located upstream from adenylate cyclase.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions</jats:title> <jats:p>Lidocaine potentiates Galphai-coupled A1R signaling by reducing cyclic adenosine monophosphate production. The study suggests an interaction site for LAs in a Galphai-coupled signaling pathway, with the Galphai protein representing the prime candidate. Taken together with previous results showing inhibitory LA interactions on the Galphaq protein subunit, the data in the current study support the hypothesis that specific G protein subunits represent alternative sites of LA action.</jats:p> </jats:sec>
container_issue 5
container_start_page 1093
container_title Anesthesiology
container_volume 99
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792335500445483012
geogr_code not assigned
last_indexed 2024-03-01T14:45:16.407Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Lidocaine+Enhances+G%CE%B1iProtein+Function&rft.date=2003-11-01&genre=article&issn=0003-3022&volume=99&issue=5&spage=1093&epage=1101&pages=1093-1101&jtitle=Anesthesiology&atitle=Lidocaine+Enhances+G%CE%B1iProtein+Function&aulast=Hollmann&aufirst=Markus%C2%A0W.&rft_id=info%3Adoi%2F10.1097%2F00000542-200311000-00015&rft.language%5B0%5D=eng
SOLR
_version_ 1792335500445483012
author Benkwitz, Claudia, Garrison, James C., Linden, Joel, Durieux, Marcel E., Hollmann, Markus W.
author_facet Benkwitz, Claudia, Garrison, James C., Linden, Joel, Durieux, Marcel E., Hollmann, Markus W., Benkwitz, Claudia, Garrison, James C., Linden, Joel, Durieux, Marcel E., Hollmann, Markus W.
author_sort benkwitz, claudia
container_issue 5
container_start_page 1093
container_title Anesthesiology
container_volume 99
description <jats:sec> <jats:title>Background</jats:title> <jats:p>Local anesthetics inhibit several G protein-coupled receptors by interaction with the Galphaq protein subunit. It is not known whether this effect on G protein function can be extrapolated to other classes of G proteins. The authors investigated interactions of lidocaine with the human adenosine 1 receptor (hA1R)-coupled signaling pathway. Activated A1Rs couple to adenylate cyclase via the pertussis toxin sensitive Galphai protein, thereby decreasing cyclic adenosine monophosphate formation. A1Rs are widely expressed and abundant in the spinal cord, brain, and heart. Interactions of LAs with the hA1R-coupled transduction cascade therefore might produce a broad range of clinically relevant effects.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>The function of hA1Rs stably expressed in Chinese hamster ovary cells was determined with assays of cyclic adenosine monophosphate, receptor binding, and guanosine diphosphate/guanosine triphosphate gamma35S exchange by using reconstituted defined G protein subunits. Involvement of phosphodiesterase and Galphai was characterized by using the phosphodiesterase inhibitor rolipram and pertussis toxin, respectively.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>Lidocaine (10-9-10-1 M) had no significant effects on agonist or antagonist binding to the hA1R or on receptor-G protein interactions. However, cyclic adenosine monophosphate levels were reduced significantly to 50% by the LAs, even in the absence of an A1R agonist or presence of an A1R antagonist. This effect was unaffected by rolipram (10 mum), but abolished completely by pretreatment with pertussis toxin, which inactivates the Galphai protein. Therefore, the main target site for LAs in this pathway is located upstream from adenylate cyclase.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions</jats:title> <jats:p>Lidocaine potentiates Galphai-coupled A1R signaling by reducing cyclic adenosine monophosphate production. The study suggests an interaction site for LAs in a Galphai-coupled signaling pathway, with the Galphai protein representing the prime candidate. Taken together with previous results showing inhibitory LA interactions on the Galphaq protein subunit, the data in the current study support the hypothesis that specific G protein subunits represent alternative sites of LA action.</jats:p> </jats:sec>
doi_str_mv 10.1097/00000542-200311000-00015
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5Ny8wMDAwMDU0Mi0yMDAzMTEwMDAtMDAwMTU
imprint Ovid Technologies (Wolters Kluwer Health), 2003
imprint_str_mv Ovid Technologies (Wolters Kluwer Health), 2003
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229
issn 0003-3022
issn_str_mv 0003-3022
language English
last_indexed 2024-03-01T14:45:16.407Z
match_str benkwitz2003lidocaineenhancesgaiproteinfunction
mega_collection Ovid Technologies (Wolters Kluwer Health) (CrossRef)
physical 1093-1101
publishDate 2003
publishDateSort 2003
publisher Ovid Technologies (Wolters Kluwer Health)
record_format ai
recordtype ai
series Anesthesiology
source_id 49
spelling Benkwitz, Claudia Garrison, James C. Linden, Joel Durieux, Marcel E. Hollmann, Markus W. 0003-3022 Ovid Technologies (Wolters Kluwer Health) Anesthesiology and Pain Medicine http://dx.doi.org/10.1097/00000542-200311000-00015 <jats:sec> <jats:title>Background</jats:title> <jats:p>Local anesthetics inhibit several G protein-coupled receptors by interaction with the Galphaq protein subunit. It is not known whether this effect on G protein function can be extrapolated to other classes of G proteins. The authors investigated interactions of lidocaine with the human adenosine 1 receptor (hA1R)-coupled signaling pathway. Activated A1Rs couple to adenylate cyclase via the pertussis toxin sensitive Galphai protein, thereby decreasing cyclic adenosine monophosphate formation. A1Rs are widely expressed and abundant in the spinal cord, brain, and heart. Interactions of LAs with the hA1R-coupled transduction cascade therefore might produce a broad range of clinically relevant effects.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>The function of hA1Rs stably expressed in Chinese hamster ovary cells was determined with assays of cyclic adenosine monophosphate, receptor binding, and guanosine diphosphate/guanosine triphosphate gamma35S exchange by using reconstituted defined G protein subunits. Involvement of phosphodiesterase and Galphai was characterized by using the phosphodiesterase inhibitor rolipram and pertussis toxin, respectively.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>Lidocaine (10-9-10-1 M) had no significant effects on agonist or antagonist binding to the hA1R or on receptor-G protein interactions. However, cyclic adenosine monophosphate levels were reduced significantly to 50% by the LAs, even in the absence of an A1R agonist or presence of an A1R antagonist. This effect was unaffected by rolipram (10 mum), but abolished completely by pretreatment with pertussis toxin, which inactivates the Galphai protein. Therefore, the main target site for LAs in this pathway is located upstream from adenylate cyclase.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions</jats:title> <jats:p>Lidocaine potentiates Galphai-coupled A1R signaling by reducing cyclic adenosine monophosphate production. The study suggests an interaction site for LAs in a Galphai-coupled signaling pathway, with the Galphai protein representing the prime candidate. Taken together with previous results showing inhibitory LA interactions on the Galphaq protein subunit, the data in the current study support the hypothesis that specific G protein subunits represent alternative sites of LA action.</jats:p> </jats:sec> Lidocaine Enhances GαiProtein Function Anesthesiology
spellingShingle Benkwitz, Claudia, Garrison, James C., Linden, Joel, Durieux, Marcel E., Hollmann, Markus W., Anesthesiology, Lidocaine Enhances GαiProtein Function, Anesthesiology and Pain Medicine
title Lidocaine Enhances GαiProtein Function
title_full Lidocaine Enhances GαiProtein Function
title_fullStr Lidocaine Enhances GαiProtein Function
title_full_unstemmed Lidocaine Enhances GαiProtein Function
title_short Lidocaine Enhances GαiProtein Function
title_sort lidocaine enhances gαiprotein function
title_unstemmed Lidocaine Enhances GαiProtein Function
topic Anesthesiology and Pain Medicine
url http://dx.doi.org/10.1097/00000542-200311000-00015